Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Podcast
In this episode, we uncover the strategies and innovations behind recent pharmaceutical breakthroughs. Despite intense competition and the shifting landscape of Medicare Part D, Incyte continues to lead with strategic maneuvers and a patient-centered approach. We’ll delve deeper into Opzelura, an FDA-approved treatment for AD and vitiligo, shedding light on the financial and emotional burdens of these conditions and the high stakes of drug development.
Explore the future of pharmaceuticals as we discuss how model-informed drug development (MIDD), powered by AI and predictive simulations, is transforming the testing process, making it faster and safer. We also highlight the role of patient advocacy groups in shaping the drug pricing landscape, ensuring real-world voices are heard in industry decisions. This episode provides a deep dive into the business, science, and human impact of modern pharmaceuticals, offering a fresh perspective on the challenges and promises that lie ahead.
OVERVIEW
(0:00:00) - The World of Pharmaceuticals
In this segment, we dive into Incyte's success with Jakafi, exploring how they’ve navigated competition and Medicare changes to reach over a billion in quarterly revenue. We also look at their latest product, Opzelura, and discuss the profound emotional and financial tolls of conditions like vitiligo, eczema and atopic dermatitis.
(0:08:47) - Innovations in Drug Development and Patient Advocacy
Here, we explore the potential of AI-driven model-informed drug development (MIDD) to revolutionize drug testing. We also highlight the role of patient advocacy groups in shaping the drug pricing landscape, ensuring real-world voices are heard in industry decisions

FAQOther Questions
- Is it Bitiligo? Vitaligo? Veteligo?
There are so many different ways that people try and spell or even pronounce Vitiligo. Here are some common mis-spellings: bitiligo, vitigo, vitaligo, vitilago, vitiglio, vita...
- I have vitiligo: will my children have vitiligo, too?
If you have vitiligo, you might wonder about the chances of your children developing the condition. While there is a genetic component, vitiligo is not a straightforward heredit...
- How long does it take to treat vitiligo?
Vitiligo, a condition characterized by the loss of skin pigment, can be unpredictable in both progression and treatment. The time it takes to treat vitiligo varies significantly...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.